AI-Powered pulse check could spot hidden heart defects in newborns

NCT ID NCT05637814

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether a machine learning algorithm can better detect critical congenital heart disease (CCHD) in newborns by combining standard oxygen saturation measurements with perfusion index data. Researchers will enroll up to 320 infants, including those with suspected or confirmed heart conditions and healthy babies. The goal is to see if the AI approach improves screening accuracy compared to current methods.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
SpO2/PIx measurement and ML algorithm
What this could lead to
If successful, this could make newborn screening for critical heart defects more accurate, catching more cases early and reducing missed diagnoses.
What could go wrong
This is a validation study, not a treatment trial. The algorithm may not perform better than current screening methods, and results may not apply to all hospitals or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cohen Children's Medical Center

    NOT_YET_RECRUITING

    Queens, New York, 11040, United States

  • UC Davis Medical Center

    RECRUITING

    Davis, California, 95616, United States

  • University of Utah Health Care

    NOT_YET_RECRUITING

    Salt Lake City, Utah, 84102, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.